Merck Sells DoD Financed Covid Pill Molnupiravir At 40 Times The Cost Price

A 5 day course of molnupiravir, costs $17.74 to produce, according to a report (read below) published by The Intercept issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London.


However, Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

A small Miami-based company, Ridgeback licensed the medicine from Emory University in 2020 and two months later sold the worldwide rights to the drug to Merck for an undisclosed sum.

Although Ridgeback remains involved in the development of the drug, some have described the deal as “flipping.”

Read More